Loss of <i>DKK3</i> mRNA expression is associated with reduced recurrence-free survival (RFS) in breast cancer patients.
- Eva Lorsy (3145854)
- Aylin Sophie Topuz (3145866)
- Cordelia Geisler (3145860)
- Sarah Stahl (3145857)
- Stefan Garczyk (724332)
- Saskia von Stillfried (724333)
- Mareike Hoss (1668994)
- Oleg Gluz (3145863)
- Arndt Hartmann (42756)
- Ruth Knüchel (42757)
- Edgar Dahl (42758)
Publication date
July 2016
DOIAbstract
<p>Univariate Kaplan-Meier survival analysis of data obtained from the Kaplan-Meier Plotter portal illustrating RFS in patients with high <i>DKK3</i> (red curve) compared to patients with low <i>DKK3</i> mRNA expression (black curve) in (A) tumors of all subtypes, (B) basal subtype, (C) HER2-positive subtype, (D) luminal A subtype and (E) luminal B subtype. Vertical lines: censored cases. HR = Hazard ratio, 95% CI = 95% confidence interval.</p
Add to ORKG